Quantcast

North Bay Business Journal

Wednesday, October 24, 2012, 1:12 pm

Osseon device receives U.S. approval

Print Friendly Print Friendly    

Share this item

    Osseon TherapeuticsSANTA ROSA — Osseon Therapeutics, Inc. today announced the commercial release in the U.S. of its newest device for treating bones and joints, following federal regulatory approval.

    The U.S. Food and Drug Administration approved the Osseoflex SB steerable inflatable bone tamp, which aims to treat degenerative bone and joint problems such as vertebral compression fractures.

    The Santa Rosa-based device maker said it recently completed a successful launch and distribution in Europe.

    Osseon (707-636-5940, osseon.com) claims its patented, steerable delivery system offers more treatment options than other commercial solutions while offering significant advantages in procedural efficiency and cost.

    Copyright © 1988–2014 North Bay Business Journal
    View the policy for linking to website content.

    Print Friendly Print Friendly    

    Submit Your Comments

    Required

    Required, will not be published

    Comments are moderated and generally will be posted if they are on-topic and not abusive. For more information, please see our Comments and Letters Policy. To share this item by email or social media, use the links above.

    Do not use this form to contact people, companies or organizations mentioned in this story. Contact them directly. Private messages left here will be deleted.